Elbow Lesion Market - Global Industry Analysis 2024

Elbow Lesion Market Overview

An elbow joint is made up of three bones namely, humerus, radius, and ulna. There are several important muscles that cross the elbow joint giving the strength and movement. Elbow disorder may involve arm muscles, elbow ligaments, tendons, and bones in the arm. Chronic pain of extensors at the elbow is known as tennis elbow. Over use of elbow and sports injuries can cause various elbow conditions. Golfers, Baseball pitchers, tennis players, and boxers are most susceptible to elbow disorders. Different types of elbow disorders include medial epicondylitis, lateral epicondylitis, olecranon bursitis, osteoarthritis, dislocation or fracture of the elbow, ligaments strains and sprains, and osteochondritis dissecans. Elbow disorders can be diagnosed by physical examination and studying patient history, x-rays, computerized tomography scan, magnetic resonance imaging, electromyography, and biopsy of bursa fluid.

Get Free PDF Research Brochure for more Professional and Technical Insights: https://www.coherentmarketinsights.com/insight/request-sample/96

Increasing geriatric population highly prone to bone injury and rising number of sports related injuries driving growth of the elbow lesion market

Rise in prevalence of elbow tendon, increasing incidence of elbow joint pain, and growth in healthcare investment are factors driving growth of the global market for elbow lesion. According to the National Institute for Health and Care Excellence (NICE) tennis elbow was prevalent in 1%-3% of UK population in 2012. It has been observed that people above 60 years are more afflicted with elbow pain. Therefore, rapidly growing geriatric population and increasing incidence of arm fracture due to accidents are expected to drive growth of the elbow lesion market in the near future.

Platelet-rich plasma – An effective antidote for tennis elbow

The elbow lesion market is classified on the basis of treatment methods into surgical and non-surgical therapies. Arthroscopic surgery and open surgery are types of surgical therapies performed. Non-surgical therapies comprise drugs and physical therapy.

Various non-steroidal anti-inflammatory drugs (NSAIDS) such as ibuprofen, aspirin, and cortisone are administered to control pain. Other drugs used for treatment of elbow pain include botulinum toxin and hyaluronate propelling growth of the elbow lesion market. Platelet-rich plasma (PRP), a novel technique, is being preferred for treatment of tennis elbow. It involves taking a blood sample from the patient, which is then treated to increase the number of platelets compared with other cells in the sample. Physical therapies such as muscle stimulation and ice massage are used to expedite the healing process.

Rising number of sports injuries drives growth of the elbow lesion market in North America

Increasing number of sports events and competitions in the U.S, increasing patient awareness, good medical facilities, and favorable reimbursement policies are factors fueling growth of the elbow lesion market. Elbow injuries are considered to be an expected consequence of throwing sports. According to a study published in Orthopaedic Journal of Sports Medicine in 2013, 30% of baseball players will have elbow pain every year, and nearly 60% of players with elbow pain will show radiographic abnormalities. The elbow lesion market in emerging markets such as India, China, Russia, and Brazil is growing due to increase in number of sports injuries in these regions, use of advanced technology in diagnosis, and improving medical facilities offered by government and private companies.

Browse Research Report At : https://www.coherentmarketinsights.com/ongoing-insight/elbow-lesion-market-96

Key players engaged in the elbow lesion market

Key manufacturers of elbow braces for athletes include Mueller Sports Medicine and Professional Orthopedic Products, among others.

ABOUT US
COMPANY OVERVIEW
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. Our client base includes players from across all business verticals in over 150 countries worldwide. We are uniquely positioned to help businesses around the globe deliver practical and lasting results through various recommendations about operational improvements, technologies, emerging market trends and new working methods. We offer both customized and syndicated market research reports that help our clients create visionary growth plans to provide traction to their business. We meticulously study emerging trends across various industries at both the global and regional levels to identify new opportunities for our clientele. Our global team of over 100 research analysts and freelance consultants provide market intelligence from the very molecular country level and also provide a global perspective of the market. Our team is of the most vital cog in our robust machinery that gives us the ability to deliver independent insight relying on our cognitive defusion training module.This allows for an objective and unbiased assessment of the market. We pride ourselves in my constantly striving to update our extremely in-depth understanding of the market by closely monitoring and analyzing markets, trends, and emerging best practices, across allfathomable industries under the sun. This enables us to equip our valued clientele with key decisive inputs to capitalize on lucrative growth opportunities in the market and to follow firmly position themselves on a high growth path in the future.

CONTACT US
CORPORATE OFFICE:
Coherent Market Insights
303, Astral Court,Above Reliance Fresh,
Near Gaikwad Petrol Pump,
Aundh, Pune – 411045, India
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com
Website: https://www.coherentmarketinsights.com/
Visit Blog : http://globalresearchtrends.blogspot.in/

This release was published on openPR.